Realistically speaking, I expect gross sales to be about 1.6 million for the quarter ending December 31, 2012. Most of the sales will be government related, where insurance reimbursement is not an issue. But there is a lot of competition and very little marketing and neglible promotion. We will have to wait until next quarter to get better results and perhaps by then we will be getting some real dollars from Prochymal, Grafix and Ovation sales. At this time, income is not that important. Too many other key factors will be determined in the next month or two that could propel the stock value significantly higher.